Synonyms: TB-500, Thymosin Beta-4, Thymosin 4
Clinical trials by Walker et al
Disclosure of interest: Chak Lam Ip: Nothing to disclose Sooyeon Han: Nothing to disclose Hannah Eskender: Nothing to disclose Agnieszka Dados: Nothing to disclose Arvind Chandratheva: Nothing to disclose Rob Simister: Nothing to disclose Poster Session I - PRE-HOSPITAL SERVICE ORGANISATION 09.00 - PRE-HOSPITAL SERVICE ORGANISATION - 09.01 - PRE-HOSPITAL SERVICE ORGANISATION P199 - ESOC25-2317 FROM SYMPTOMS TO SPECIALIST: OPTIMISING TIA PATHWAYS WITH PREHOSPITAL VIDEO TRIAGE Chak Lam Ip 1 , Agnieszka Dados 1 , Sooyeon Han *1,2 , Hannah Eskender 1,2 , Fahm Deen 1,2 , Arvind Chandratheva 1 , Rob Simister 1 1 University College London Hospitals NHS Foundation Trust, London, United Kingdom, 2 University College London Medical School, London, United Kingdom Background and Aims: National guidelines recommend suspected Transient Ischaemic Attack (TIA) be appropriately managed by a stroke specialist within 24 hours of symptom onset, which is challenging under conventional pathways, where patients in the UK are initially evaluated by Emergency Departments (ED) or General Practitioners (GP) before referral
As peptides are involved in an immense number of physiological processes, it was logical to further exploit them for cosmetic applications
To initiate the process, you can either consult with your GP for a test or arrange it privately through our clinic
Apart from red-colored urine (in case of intravenous administration), innocent skin discoloration, and possible soft stools, no side effects have been reported at the intervention evaluation
